Skip to main content

Table 1 The characteristics of CAD patients and controls

From: Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population

Characteristics

CAD (n = 626)

Controls (n = 470)

χ2(t)

P

Age (years)

64.18 ± 9.83

61.62 ± 9.42

4.337

< 0.01

Male [n (%)]

439 (70.13)

243 (51.70)

38.774

< 0.01

EH [n (%)]

454 (72.52)

276 (58.72)

22.986

< 0.01

DM [n (%)]

163 (26.04)

67 (14.26)

22.478

< 0.01

Smoking [n (%)]

239 (38.18)

114 (24.26)

23.835

< 0.01

TC (mmol/l)

4.59 ± 1.05

4.42 ± 0.96

2.807

< 0.01

TG (mmol/l)

1.84 ± 1.50

1.76 ± 1.46

0.949

> 0.05

HDL-C (mmol/l)

1.08 ± 0.27

1.16 ± 0.31

4.752

< 0.01

LDL-C (mmol/l)

2.93 ± 0.92

2.64 ± 0.79

5.572

< 0.01

ApoA1 (g/l)

1.18 ± 0.23

1.23 ± 0.24

3.691

< 0.01

ApoB (g/l)

1.16 ± 0.31

1.08 ± 0.27

3.789

< 0.01

  1. CAD coronary artery disease, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, EH essential hypertension, DM diabetes mellitus